Nasdaq · CIK 0002020737
CABR Caring Brands, Inc.
Insider trading from SEC Form 4. Last filing 13 d ago.
In brief
Caring Brands, Inc. (CABR) has 13 SEC Form 4 filings on file from 7 insiders, the latest filed on Sep 30, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Caring Brands, Inc., scored.
Transactions
Every row filed, 15 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Hector W Alila director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 75,000 | 13 d ago |
| Sep 28, 2026 | Brian Meadows Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | 13 d ago |
| Sep 28, 2026 | Christopher Matthew Galeta director | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 50,000 | 13 d ago |
| Sep 28, 2026 | Christopher Melton director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 75,000 | 13 d ago |
| Jul 23, 2026 | Brian John Interim CFO | JOther Common Stock | -150,000 | $1.00 | $150k | 600,000 | Jul 28, 2026 |
| Mar 27, 2026 | Brian John Interim CFO | DDisposition to issuer Common Stock | -1,250,000 | $1.00 | $1.3M | 750,000 | Mar 27, 2026 |
| Mar 27, 2026 | Glynn Wilson Chief Executive Officer | DDisposition to issuer Common Stock | -1,500,000 | $0.50 | $750k | 672,592 | Mar 27, 2026 |
| Dec 11, 2025 | Hector W Alila director | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Dec 16, 2025 |
| Dec 11, 2025 | Tyler Thomas Moore Chief Financial Officer | AGrant or award Common Stock | -270,000 | $0.00 | $0 | 270,000 | Dec 15, 2025 |
| Dec 11, 2025 | Glynn Wilson Chief Executive Officer | AGrant or award Common Stock | -126,720 | $0.00 | $0 | 2,126,720 | Dec 15, 2025 |
| Dec 11, 2025 | Christopher Matthew Galeta director | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Dec 15, 2025 |
| Dec 11, 2025 | Christopher Melton director | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Dec 15, 2025 |
| Dec 11, 2025 | Brian John Interim CFO | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Dec 15, 2025 |
| Dec 11, 2025 | Tyler Thomas Moore Chief Financial Officer | AGrant or award Common Stock | -30,000 | $0.00 | $0 | 300,000 | Dec 15, 2025 |
| Dec 11, 2025 | Glynn Wilson Chief Executive Officer | AGrant or award Common Stock | -45,872 | $0.00 | $0 | 2,172,592 | Dec 15, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Hector W Aliladirector
- Christopher Matthew Galetadirector
- Brian JohnInterim CFO
- Brian MeadowsChief Financial Officer
- Christopher Meltondirector
- Tyler Thomas MooreChief Financial Officer
- Glynn WilsonChief Executive Officer
Questions about CABR
Answered from the filings on this page, as of the latest one.
Are insiders buying CABR?
No. In the last 90 days no insider at Caring Brands, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CABR on the open market?
No open-market trade has been scored at Caring Brands, Inc.. The latest Form 4 on file was filed on Sep 30, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Caring Brands, Inc.?
7 people have filed a Form 4 at Caring Brands, Inc., among them Hector W Alila (director), Christopher Matthew Galeta (director), Brian John (Interim CFO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.